ALB and diabetes mellitus: Clinical trials, such as the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) study and SUSTAIN-6, have shown that liraglutide and semaglutide can reduce urinary albumin excretion and protect kidney function [59,60].